Jun 2, 2018

New blood test could be the ‘holy grail of cancer research’

Posted by in category: biotech/medical

A blood test could one day save millions by allowing doctors to screen for cancer before patients show symptoms.

The test, called a “liquid biopsy,” screens for 10 types of the disease by detecting trace amounts of DNA released into the bloodstream by cancer cells. So far, it has proven particularly capable of detecting ovarian and pancreatic cancer, both of which have significantly lower mortality rates when caught early enough to perform surgery as a means of removing the cancer. Unfortunately, most are caught after patients begin to show symptoms, which is often after the cancer has spread to other parts of the body.

“This is potentially the holy grail of cancer research, to find cancers that are currently hard to cure at an earlier stage when they are easier to cure,” says Dr. Eric Klein of Cleveland Clinic’s Taussig Cancer Institute. “We hope this test could save many lives.”

Read more


Comment — comments are now closed.

  1. Penny Zachary says:

    I would like to volunteer for the new cancer blood test screenings. Both my parents died from lung cancer. My dad passed 5 months from diagnosis and my mom 1 year. I sure would like to know sooner that later.